Detalhe da pesquisa
1.
Characterizing the COVID-19 Illness Experience to Inform the Study of Post-acute Sequelae and Recovery.
Int J Behav Med
; 29(5): 610-623, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34918211
2.
Persistence, Magnitude, and Patterns of Postacute Symptoms and Quality of Life Following Onset of SARS-CoV-2 Infection: Cohort Description and Approaches for Measurement.
Open Forum Infect Dis
; 9(2): ofab640, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35106317
3.
Characterizing the COVID-19 illness experience to inform the study of post-acute sequelae and recovery: a qualitative study.
medRxiv
; 2021 Mar 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33758881
4.
Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms.
Cell Rep
; 36(6): 109518, 2021 08 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34358460
5.
Long-Term SARS-CoV-2-Specific Immune and Inflammatory Responses Across a Clinically Diverse Cohort of Individuals Recovering from COVID-19.
medRxiv
; 2021 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33688685
6.
Rapid implementation of a cohort for the study of post-acute sequelae of SARS-CoV-2 infection/COVID-19.
medRxiv
; 2021 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33758895
7.
SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay.
Sci Adv
; 7(31)2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34330709
8.
SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay.
medRxiv
; 2021 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33688675